Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 13 studies | 44% ± 15% | |
epithelial cell | 5 studies | 31% ± 9% | |
goblet cell | 4 studies | 16% ± 1% | |
oligodendrocyte | 4 studies | 21% ± 4% | |
endothelial cell | 3 studies | 17% ± 0% | |
myeloid cell | 3 studies | 20% ± 2% | |
GABAergic neuron | 3 studies | 29% ± 4% | |
glutamatergic neuron | 3 studies | 35% ± 5% | |
macrophage | 3 studies | 24% ± 7% | |
astrocyte | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1633.89 | 459 / 459 | 100% | 33.87 | 1114 / 1118 |
esophagus | 100% | 1643.48 | 1445 / 1445 | 99% | 23.03 | 182 / 183 |
brain | 100% | 1125.56 | 2630 / 2642 | 100% | 28.66 | 703 / 705 |
lung | 99% | 1217.85 | 575 / 578 | 99% | 16.84 | 1147 / 1155 |
pancreas | 100% | 814.81 | 327 / 328 | 99% | 20.13 | 176 / 178 |
skin | 100% | 1713.45 | 1808 / 1809 | 99% | 35.18 | 465 / 472 |
prostate | 100% | 1437.75 | 245 / 245 | 98% | 14.47 | 494 / 502 |
intestine | 100% | 2063.87 | 965 / 966 | 98% | 19.09 | 519 / 527 |
uterus | 100% | 1661.43 | 170 / 170 | 98% | 17.41 | 449 / 459 |
stomach | 100% | 1289.25 | 359 / 359 | 98% | 19.40 | 279 / 286 |
bladder | 100% | 1476.90 | 21 / 21 | 96% | 15.03 | 485 / 504 |
kidney | 100% | 1007.75 | 89 / 89 | 96% | 16.12 | 866 / 901 |
thymus | 100% | 1366.66 | 653 / 653 | 96% | 14.01 | 581 / 605 |
ovary | 100% | 1212.89 | 180 / 180 | 95% | 10.24 | 410 / 430 |
liver | 100% | 1605.62 | 226 / 226 | 95% | 14.15 | 387 / 406 |
adrenal gland | 100% | 1236.97 | 258 / 258 | 90% | 10.12 | 207 / 230 |
adipose | 100% | 1387.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1314.29 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 67.47 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.66 | 1 / 1 |
muscle | 100% | 1842.14 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 602.27 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 1090.21 | 832 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.40 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 62% | 4.17 | 18 / 29 |
peripheral blood | 21% | 132.45 | 194 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006952 | Biological process | defense response |
GO_0016567 | Biological process | protein ubiquitination |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0040008 | Biological process | regulation of growth |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0010498 | Biological process | proteasomal protein catabolic process |
GO_0001772 | Cellular component | immunological synapse |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0046935 | Molecular function | 1-phosphatidylinositol-3-kinase regulator activity |
Gene name | SOCS6 |
Protein name | Suppressor of cytokine signaling 6 Suppressor of cytokine signaling 6 (SOCS-6) (Cytokine-inducible SH2 protein 4) (CIS-4) (Suppressor of cytokine signaling 4) (SOCS-4) |
Synonyms | CIS4 SOCS4 |
Description | FUNCTION: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. May be a substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). Regulates KIT degradation by ubiquitination of the tyrosine-phosphorylated receptor. . |
Accessions | J3KTM7 ENST00000582322.1 ENST00000397942.4 ENST00000578377.1 O14544 |